| Symbol | IXHL |
|---|---|
| Name | INCANNEX HEALTHCARE INC. |
| Sector | HEALTH CARE |
| Region | Oceania |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | RIALTO SOUTH TOWER,LEVEL 23,525 COLLINS STREET, MELBOURNE, 3008, Australia |
| Telephone | +61 409 - 840 786 |
| Fax | — |
| — | |
| Website | https://www.incannex.com.au |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001873875 |
| Description | Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. Additional info from NASDAQ: |
Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea
Read more(85% Positive) INCANNEX HEALTHCARE INC. (IXHL) Announces Enrollment Update for Treatment Due to Patient Enrollment Issues, Regulatory Process, Efficacy Assessment
Read moreIncannex Announces Initiation of Research Coverage by Alliance Global Partners
Read more(95% Neutral) INCANNEX HEALTHCARE INC. (IXHL) Provides Update on medicines for generalized anxiety disorder
Read moreIncannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea
Read more(90% Positive) INCANNEX HEALTHCARE INC. (IXHL) Announces Enrollment Update for partner Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
Read more(75% Positive) INCANNEX HEALTHCARE INC. (IXHL) Provides Update on Award for oxygenation
Read more(30% Negative) INCANNEX HEALTHCARE INC. (IXHL) Announces Delay in Treatments Trials for Serious Mental Illness Due to Pandemic-Related Challenges, Regulatory Process, Safety Review
Read more(98% Neutral) INCANNEX HEALTHCARE INC. (IXHL) Provides Update on shares for recent periods
Read moreIncannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position
Read more